Clinical benefit of ipilimumab in patients with metastatic melanoma who progress on high-dose IL-2.
R. W. Joseph
No relevant relationships to disclose
P. Hwu
No relevant relationships to disclose
M. A. Davies
No relevant relationships to disclose
M. B. Atkins
No relevant relationships to disclose
R. J. Sullivan
No relevant relationships to disclose